VVUS

Recent Articles

VVUS: VIVUS Stock Drops Following Piper Jaffray Downgrade

VIVUS stock (VVUS) has taken a hit following a downgrade by equities research analysts at Piper Jaffray. More 

Bad Day for VIVUS: Why VVUS Stock Is Tumbling

Shares of VIVUS fell sharply in Tuesday trading after the company posted a smaller quarterly loss as investors worried about the sales of its Qsymia drug. More 

3 Pharmaceutical Stocks to Sell Now

This week, the overall grades of three pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

This week, the overall grades of three pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

This week, the overall grades of three pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of three pharmaceutical stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

3 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of three pharmaceutical stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More